ClinicalTrials.Veeva

Menu
Z

Zealand University Hospital, Roskilde | Clinical Research Unit

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Cyclophosphamide
Capecitabine
R-CHOP
Prednisone
Doxorubicin Hydrochloride
Vincristine
Ensifentrine

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 7 total trials

A Study to Evaluate Change in Disease Activity of Subcutaneous (SC) Epcoritamab Combined With Intravenous and Oral Rituximab, Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine, and Prednisone (R-CHOP) or R-CHOP in Adult Participants With Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL) (EPCORE DLBCL-2)

B-cell Lymphoma is an aggressive and rare cancer of a type of immune cells (a white blood cell responsible for fighting infections). The purpose of t...

Enrolling
Diffuse Large B-Cell Lymphoma
Drug: Epcoritamab
Drug: Cyclophosphamide

This is a Phase 3, randomized, parallel-group, comparator-controlled, observer-blind, multicenter study of immunogenicity and safety in approximately...

Active, not recruiting
Influenza, Human
Biological: licensed QIV1
Biological: licensed QIV2

Trial sponsors

Genmab logo
Rigshospitalet logo
Seqirus logo
V
A
N
V

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems